Genome-wide association study identifies variants associated with autoimmune hepatitis type 1

…, NMF van Gerven, A Zwiers, BJ Verwer, B van Hoek… - Gastroenterology, 2014 - Elsevier
Background & Aims Autoimmune hepatitis (AIH) is an uncommon autoimmune liver disease
of unknown etiology. We used a genome-wide approach to identify genetic variants that …

Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission

…, B van Hoek, MJ Coenraad, KJ van Erpecum… - Journal of …, 2013 - Elsevier
BACKGROUND & AIMS: Current treatment strategies in autoimmune hepatitis (AIH) include
long-term treatment with corticosteroids and/or azathioprine. Here we determined the risk of …

Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands

…, B van Hoek, MJ Coenraad… - Scandinavian journal …, 2014 - Taylor & Francis
Background and aims. Epidemiological data on autoimmune hepatitis (AIH) are scarce. In this
study, we determined the clinical and epidemiological characteristics of AIH patients in the …

[HTML][HTML] Structural dynamics of green fluorescent protein alone and fused with a single chain Fv protein

MA Hink, RA Griep, JW Borst, A Van Hoek… - Journal of Biological …, 2000 - ASBMB
Structural information on intracellular fusions of the green fluorescent protein (GFP) of the
jellyfish Aequorea victoria with endogenous proteins is required as they are increasingly used …

The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes

…, G Bouma, JT Brouwer, B van Hoek - Alimentary …, 2011 - Wiley Online Library
Aliment Pharmacol Ther 2011; 34: 335–343 Summary Background Treatment failure occurs
in 20% of autoimmune hepatitis patients on prednisolone and azathioprine (AZA). There is …

[HTML][HTML] Risk factors for infection after liver transplantation

B van Hoek, BJ de Rooij, HW Verspaget - Best practice & research Clinical …, 2012 - Elsevier
Infection is a common cause of morbidity and mortality after liver transplantation. Risk factors
relate to transplantation factors, donor and recipient factors. Transplant factors include …

Safety of anti-TNF treatment in liver transplant recipients: a systematic review and meta-analysis

MJ Westerouen van Meeteren, B Hayee… - Journal of Crohn's …, 2017 - academic.oup.com
Background and Aim Little is known about the risk of serious infection when combining anti-tumour
necrosis factor [TNF] therapy for refractory inflammatory bowel disease [IBD] with …

Predniso (lo) ne dosage and chance of remission in patients with autoimmune hepatitis

…, B van Hoek, G Bouma, CMJ van Nieuwkerk… - Clinical …, 2019 - Elsevier
Background & Aims Patients with autoimmune hepatitis (AIH) commonly receive induction
therapy with predniso(lo)ne followed by maintenance therapy with azathioprine. European …

Adverse events related to low dose corticosteroids in autoimmune hepatitis

…, YS de Boer, B van Hoek… - Alimentary …, 2019 - Wiley Online Library
Background Autoimmune hepatitis requires long‐term therapy, and systemic corticosteroids
are the backbone of therapeutic management. Prolonged use of corticosteroids may lead to …

[HTML][HTML] Outcomes in octogenarians and the effect of comorbidities after intact abdominal aortic aneurysm repair in the Netherlands: a nationwide cohort study

…, A van der Elst, MI van Engeland, RG van Eps… - European Journal of …, 2021 - Elsevier
Objective Age is an independent risk factor for mortality after both elective open surgical
repair (OSR) and endovascular aneurysm repair (EVAR). As a result of an ageing population, …